CAPAD

Welcome to the Brand page for “CAPAD”, which is offered here for Research and development in the pharmaceutical, biomedical and biotechnological fields, research into and development of protein binders for use as antibody mimetics in pharmaceutical treatments; custom design and engineering of protein binders using a proprietary platform and process that leverages high-throughput screening and artificial intelligence; consultation services in the field of pharmaceutical, biomedical and biotechnological research relating to binder proteins;.

Its status is currently believed to be active. Its class is unavailable. “CAPAD” is believed to be currently owned by “20n Bio Inc.”